Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Pricing Sign in

Addex Therapeutics Ltd ADXN

Full chart Compare
Set alert

Price alert · ADXN

All alert types
2.84 USD -0.12 (-3.90%)

Nov 11, 2026, 11:06 AM EST

2.86 Day range 2.89
2.56 52-week range 10.43
YTD
-63.15%
1 year
-67.71%

Financial health

Altman Z-Score

-150.64 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

C+2 / 5 overall

  • DCF 3
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 2

Valuation

P/E -0.9×
FY 2016: -6.8×FY 2017: -7.3×FY 2018: -26.2×FY 2019: -3.3×FY 2020: -4.1×FY 2021: -2.1×FY 2022: -0.2×FY 2023: -0.3×FY 2024: 0.8×FY 2025: -0.9×
FY 2016 5y median -0.3× FY 2025
P/S 191×
FY 2016: 1262×FY 2017: 47.5×FY 2018: 7.1×FY 2019: 17.4×FY 2020: 14.6×FY 2021: 11.2×FY 2022: 3.1×FY 2023: 2.0×FY 2024: 12.9×FY 2025: 191×
FY 2016 5y median 11.2× FY 2025
P/B 1.2×
FY 2016: 100×FY 2017: 17.7×FY 2018: 1.1×FY 2019: 1.9×FY 2020: 3.6×FY 2021: 1.9×FY 2022: 0.9×FY 2023: 2.7×FY 2024: 0.5×FY 2025: 1.2×
FY 2016 5y median 1.2× FY 2025
P/FCF -2.8×
FY 2016: -8.1×FY 2017: -11.1×FY 2018: 24.8×FY 2019: -5.1×FY 2020: -4.3×FY 2021: -2.2×FY 2022: -0.3×FY 2023: -0.4×FY 2024: -1.0×FY 2025: -2.8×
FY 2016 5y median -1.0× FY 2025
EV/EBITDA -0.6×
FY 2016: -6.6×FY 2017: -6.6×FY 2018: -1.0×FY 2019: -1.2×FY 2020: -2.8×FY 2021: -0.8×FY 2022: 0.2×FY 2023: 0.2×FY 2024: -0.4×FY 2025: -0.6×
FY 2016 5y median -0.4× FY 2025
EV/Sales 137×
FY 2016: 1180×FY 2017: 42.3×FY 2018: 0.2×FY 2019: 6.2×FY 2020: 9.6×FY 2021: 4.3×FY 2022: -1.5×FY 2023: -0.2×FY 2024: 4.7×FY 2025: 137×
FY 2016 5y median 4.3× FY 2025
FCF Yield -36.3%
FY 2016: -12.4%FY 2017: -9.0%FY 2018: 4.0%FY 2019: -19.8%FY 2020: -23.2%FY 2021: -45.2%FY 2022: -374.9%FY 2023: -254.0%FY 2024: -103.5%FY 2025: -36.3%
FY 2016 5y median -103.5% FY 2025

Profitability

Gross Margin 100.0%
FY 2016: 0.0%FY 2017: 94.0%FY 2018: 97.6%FY 2019: 91.7%FY 2020: 100.0%FY 2021: 100.0%FY 2022: 100.0%FY 2023: 100.0%FY 2024: 100.0%FY 2025: 100.0%
FY 2016 5y median 100.0% FY 2025
Operating Margin -9390.8%
FY 2016: -18059.9%FY 2017: -647.1%FY 2018: -23.6%FY 2019: -528.6%FY 2020: -338.9%FY 2021: -531.7%FY 2022: -741.0%FY 2023: -139.1%FY 2024: -681.8%FY 2025: -9390.8%
FY 2016 5y median -681.8% FY 2025
Net Margin -22448.4%
FY 2016: -18174.1%FY 2017: -656.2%FY 2018: -27.2%FY 2019: -535.0%FY 2020: -355.9%FY 2021: -526.4%FY 2022: -1462.6%FY 2023: -654.5%FY 2024: 1746.0%FY 2025: -22448.4%
FY 2016 5y median -654.5% FY 2025
ROE -141.1%
FY 2016: -1440.8%FY 2017: -244.3%FY 2018: -4.2%FY 2019: -57.9%FY 2020: -88.0%FY 2021: -90.7%FY 2022: -423.5%FY 2023: -921.6%FY 2024: 72.9%FY 2025: -141.1%
FY 2016 5y median -141.1% FY 2025
ROIC -54.4%
FY 2016: -722.7%FY 2017: -203.9%FY 2018: -3.6%FY 2019: -52.7%FY 2020: -72.6%FY 2021: -82.9%FY 2022: -199.4%FY 2023: -110.9%FY 2024: -27.9%FY 2025: -54.4%
FY 2016 5y median -82.9% FY 2025
ROA -105.7%
FY 2016: -187.1%FY 2017: -107.1%FY 2018: -3.9%FY 2019: -44.8%FY 2020: -63.7%FY 2021: -68.1%FY 2022: -251.2%FY 2023: -227.4%FY 2024: 66.1%FY 2025: -105.7%
FY 2016 5y median -105.7% FY 2025

Growth (YoY)

Revenue -92.6%
FY 2016: -57.0%FY 2017: 2784.7%FY 2018: 1109.0%FY 2019: -54.3%FY 2020: 30.8%FY 2021: -19.3%FY 2022: -51.2%FY 2023: 13.4%FY 2024: -74.9%FY 2025: -92.6%
FY 2016 FY 2025
Operating Income -2.2%
FY 2016: 19.1%FY 2017: -3.4%FY 2018: 56.0%FY 2019: -925.1%FY 2020: 16.2%FY 2021: -26.6%FY 2022: 32.0%FY 2023: 78.7%FY 2024: -22.8%FY 2025: -2.2%
FY 2016 FY 2025
EPS (diluted) -181.9%
FY 2016: 28.2%FY 2017: 10.7%FY 2018: 71.8%FY 2019: -693.2%FY 2020: 14.3%FY 2021: 6.2%FY 2022: -2.2%FY 2023: 69.6%FY 2024: 150.0%FY 2025: -181.9%
FY 2016 FY 2025
Free Cash Flow 61.4%
FY 2016: -2.9%FY 2017: 21.1%FY 2018: 181.6%FY 2019: -645.7%FY 2020: -28.7%FY 2021: -20.4%FY 2022: -11.5%FY 2023: 51.3%FY 2024: 32.8%FY 2025: 61.4%
FY 2016 FY 2025

Financial Health

Current Ratio 1.4×
FY 2016: 1.3×FY 2017: 2.1×FY 2018: 18.1×FY 2019: 5.7×FY 2020: 5.4×FY 2021: 5.3×FY 2022: 2.4×FY 2023: 1.5×FY 2024: 4.4×FY 2025: 1.4×
FY 2016 5y median 2.4× FY 2025
Quick Ratio 1.4×
FY 2016: 1.3×FY 2017: 2.1×FY 2018: 18.1×FY 2019: 5.7×FY 2020: 5.3×FY 2021: 5.3×FY 2022: 2.4×FY 2023: 1.5×FY 2024: 4.4×FY 2025: 1.4×
FY 2016 5y median 2.4× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.1×FY 2023: 0.3×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.2×
FY 2016: 0.5×FY 2017: 0.8×FY 2018: 27.6×FY 2019: 2.2×FY 2020: 1.5×FY 2021: 1.3×FY 2022: 0.6×FY 2023: 1.6×FY 2024: 0.7×FY 2025: 0.2×
FY 2016 5y median 0.7× FY 2025
Interest Coverage -1163×
FY 2016: -452×FY 2017: -71.3×FY 2018: -6.5×FY 2019: -114×FY 2020: -176×FY 2021: -246×FY 2022: -216×FY 2023: -104×FY 2024: -777×FY 2025: -1163×
FY 2016 5y median -246× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31